Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Methylprednisolone-induced hepatotoxicity: experiences from global adverse drug reaction surveillance
Stockholms universitet, Samhällsvetenskapliga fakulteten, Institutionen för data- och systemvetenskap. Uppsala Monitoring Centre, Sweden.ORCID-id: 0000-0002-2259-1716
2014 (Engelska)Ingår i: European Journal of Clinical Pharmacology, ISSN 0031-6970, E-ISSN 1432-1041, Vol. 70, nr 4, s. 501-503Artikel i tidskrift, Letter (Refereegranskat) Published
Ort, förlag, år, upplaga, sidor
2014. Vol. 70, nr 4, s. 501-503
Nationell ämneskategori
Farmakologi och toxikologi
Identifikatorer
URN: urn:nbn:se:su:diva-100282DOI: 10.1007/s00228-013-1632-3ISI: 000332961700017OAI: oai:DiVA.org:su-100282DiVA, id: diva2:692425
Tillgänglig från: 2014-01-31 Skapad: 2014-01-31 Senast uppdaterad: 2019-12-04Bibliografiskt granskad
Ingår i avhandling
1. Quantitative methods to support drug benefit-risk assessment
Öppna denna publikation i ny flik eller fönster >>Quantitative methods to support drug benefit-risk assessment
2014 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Abstract [en]

Joint evaluation of drugs’ beneficial and adverse effects is required in many situations, in particular to inform decisions on initial or sustained marketing of drugs, or to guide the treatment of individual patients. This synthesis, known as benefit-risk assessment, is without doubt important: timely decisions supported by transparent and sound assessments can reduce mortality and morbidity in potentially large groups of patients. At the same time, it can be hugely complex: drug effects are generally disparate in nature and likelihood, and the information that needs to be processed is diverse, uncertain, deficient, or even unavailable. Hence there is a clear need for methods that can reliably and efficiently support the benefit-risk assessment process. For already marketed drugs, this process often starts with the detection of previously unknown risks that are subsequently integrated with all other relevant information for joint analysis.

In this thesis, quantitative methods are devised to support different aspects of drug benefit-risk assessment, and the practical usefulness of these methods is demonstrated in clinically relevant case studies. Shrinkage regression is adapted and implemented for large-scale screening in collections of individual case reports, leading to the discovery of a link between methylprednisolone and hepatotoxicity. This adverse effect is then considered as part of a complete benefit-risk assessment of methylpredniso­lone in multiple sclerosis relapses, set in a general framework of probabilistic decision analysis. Two methods devised in the thesis substantively contribute to this assessment: one for efficient generation of utility distributions for the considered clinical outcomes, driven by modelling of qualitative information; and one for computing risk limits for rare and otherwise non-quantifiable adverse effects, based on collections of individual case reports.

Ort, förlag, år, upplaga, sidor
Stockholm: Department of Computer and Systems Sciences, Stockholm University, 2014. s. 94
Serie
Report Series / Department of Computer & Systems Sciences, ISSN 1101-8526 ; 14-001
Nationell ämneskategori
Systemvetenskap, informationssystem och informatik
Forskningsämne
data- och systemvetenskap
Identifikatorer
urn:nbn:se:su:diva-100286 (URN)978-91-7447-856-3 (ISBN)
Disputation
2014-03-21, Sal C, Forum 100, Isafjordsgatan 39, Kista, 10:00 (Engelska)
Opponent
Handledare
Anmärkning

At the time of the doctoral defence the following papers were unpublished and had a status as follows: Paper 6: Manuscript; Paper 7: Manuscript.

Tillgänglig från: 2014-02-27 Skapad: 2014-01-31 Senast uppdaterad: 2018-01-11Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltext

Sök vidare i DiVA

Av författaren/redaktören
Caster, Ola
Av organisationen
Institutionen för data- och systemvetenskap
I samma tidskrift
European Journal of Clinical Pharmacology
Farmakologi och toxikologi

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetricpoäng

doi
urn-nbn
Totalt: 152 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf